Analytic Investors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$274M Sell
2,322,594
-68,883
-3% -$8.36M 3.07% 1
2016
Q2
$290M Buy
2,391,477
+17,090
+0.7% +$1.94M 3.43% 1
2016
Q1
$257M Buy
2,374,387
+43,256
+2% +$4.48M 3.13% 1
2015
Q4
$239M Sell
2,331,131
-163,568
-7% -$16.4M 2.99% 1
2015
Q3
$233M Buy
2,494,699
+193,782
+8% +$18.7M 3.11% 1
2015
Q2
$224M Sell
2,300,917
-215,841
-9% -$21.6M 3.15% 1
2015
Q1
$253M Buy
2,516,758
+1,400,271
+125% +$142M 3.46% 1
2014
Q4
$117M Buy
1,116,487
+156,894
+16% +$16.5M 1.66% 12
2014
Q3
$102M Buy
959,593
+156,635
+20% +$16.2M 1.46% 9
2014
Q2
$84M Sell
802,958
-232,248
-22% -$23.5M 1.36% 13
2014
Q1
$102M Buy
1,035,206
+10,670
+1% +$989K 1.55% 10
2013
Q4
$93.8M Buy
1,024,536
+323,215
+46% +$29.8M 1.55% 13
2013
Q3
$60.8M Buy
701,321
+30,350
+5% +$2.72M 0.98% 30
2013
Q2
$57.6M Buy
+670,971
New +$56.9M 0.96% 22

Other funds holding JNJ

Analytic Investors's JNJ Position: Q3 2016 in Review

Analytic Investors reduced its Johnson & Johnson (JNJ) stake by 2.9% in Q3 2016, selling an estimated $8.36M and leaving 2,322,594 shares worth $274M. The position accounts for 3.07% of the portfolio, ranked #1.

Analytic Investors first reported a position in JNJ in Q2 2013 and has held it in 14 quarters since. The position peaked at $290M in Q2 2016. 2,227 funds tracked by Wall St. Rank hold JNJ as of Q3 2016.

  • Analytic Investors held 2,322,594 shares of Johnson & Johnson worth $274M as of Q3 2016.
  • Analytic Investors sold 68,883 Johnson & Johnson shares in Q3 2016, an estimated $8.36M.
  • Johnson & Johnson made up 3.07% of Analytic Investors's portfolio in Q3 2016, its #1 holding.
  • Analytic Investors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 14 quarters since.
  • Analytic Investors's Johnson & Johnson position peaked at $290M in Q2 2016.
  • 2,227 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.